Novel method: New Covid-19 test makes use of smartphone camera
How about swabbing your nostrils, putting the swab in a device, and getting a read-out on your phone in 15 to 30 minutes that...
Minerva Surgical’s solution to abnormal uterine bleeding
Minerva Surgical has launched a complete suite of minimally invasive devices and website to support healthcare practitioners in treating Abnormal Uterine Bleeding.
It is estimated...
Drawbridge Health ties up with University of Cambridge researchers
Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge announced the use of the OneDraw Blood Collection Device for remote...
Doing Tada Badha Malasana will give you world of benefits
Tada Badha Malasana is one of the main yoga asanas that has immense health benefits when it is performed systematically. Engineer and yoga expert...
Ampio says its study on Covid-19 patients proceeding to full open enrollment
Ampio Pharmaceuticals Inc has announced that its AP-014 Phase I inhaled Ampion clinical study in Covid-19 patients is proceeding to full open enrollment after...
Covid-19 home-test company Selfdiagnostics to apply for authorisation
Selfdiagnostics, an European based company, is planning to submit request for authorisation of its molecular diagnostic test for home and for point of care...
Most of carrying mothers with Covid-19 won’t have difficulties: Research
Vast majority of pregnant women with Covid-19 won’t have complications, said National Institutes of Health's Director Dr Francis Collins.
Quoting a study in his latest...
Diabeloop launches DBL-hu to manage highly unstable diabetes
Diabeloop said it has received CE marking for its adjustable and innovative technological solution called DBL-hu.
The solution, according Diabeloop, enhances glycemic control and satisfaction...
COMMUNITY: A global platform trial for hospitalised patients with Covid-19
Three members of the Covid Research & Development Alliance have announced the first patient enrolled in the Community Trial.
The three members are Amgen Inc,...
AstraZeneca starts Phase 2b clinical study of medicine to lower cholesterol: Ionis
Ionis Pharmaceuticals, Inc. has said that the AstraZeneca has commenced a Phase 2b clinical trial of ION449 (AZD8233).
It is an investigational antisense medicine designed...
RECOMMENDED VIDEOS
